Priority Date: 06.02.12 (FR 20120051089)

USE OF miR-199a-5p, TARGETS AND/OR INHIBITORS THEREOF FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF FIBROPROLIFERATIVE DISORDERS

  • Application ID: EP13712915
  • Status: █ The patent has been granted

Attorneys

Missing person image thumb Missing person image thumb Missing person image thumb
Company dna cabinet lavoix
no operation time available
1309.99
Lavoix
4 offices
active in Legal Services
Employment test 201 - 500 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna novagraaf
operating since 1888
1330.54
Novagraaf
Headquarter in Amsterdam and 21 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.02.2012 - Priority Date (FR 20120051089)
  • 15.08.2013 - Publication A1 (WO2013118066)
  • 17.12.2014 - Publication A1 (EP2812449)
  • 12.07.2017 - Publication B1 (EP2812449)

IPC Classification